TY - JOUR
T1 - Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetes
AU - Lundgren, V. M.
AU - Andersen, M. K.
AU - Isomaa, B.
AU - Tuomi, T.
PY - 2013/5/1
Y1 - 2013/5/1
N2 - Aims: The aim was to evaluate the impact of family history of diabetes on the phenotype of patients diagnosed with Type 2 diabetes and the frequency of susceptibility genotypes. Methods: Patients with Type 2 diabetes with family history for both Type 1 and Type 2 diabetes (FHMIX, n = 196) or Type 2 diabetes only (FHT2, n = 139) matched for age, sex, BMI and age at diagnosis, underwent an oral glucose tolerance test and a combined glucagon test and insulin tolerance test. Glutamic acid decarboxylase (GAD) antibodies and major Type 1 and Type 2 diabetes susceptibility gene variants were analysed. Patients were stratified into groups according to family history or GAD antibody positivity (GADA+, GADA-) or a combination of these (GADA+/FHMIX, GADA+/FHT2, GADA-/FHMIX, GADA-/FHT2). Results: Compared with other patients, those with FHMIX more often had GAD antibodies (14.3 vs. 4.3%, P = 0.003), and those with both FHMIX and GAD antibodies had the highest frequency of insulin deficiency (stimulated serum C-peptide < 0.7 nmol/l, GADA+/FHMIX 46.4% vs. GADA-/FHMIX 9.5% (P < 0.00001), GADA-/FHT2 4.5% (P < 0.00001), GADA+/FHT2 0%). Patients with GADA+/FHMIX more often had HLA-DQB1 risk genotypes compared with patients with GADA-/FHMIX or GADA-/FHT2D (47 vs. 23 or 14%, P = 0.05 and P < 0.00001, respectively). In logistic regression analyses, FHMIX, GAD antibody positivity and HLA risk genotypes were independently associated with insulin deficiency. Conclusion: A family history for both type 1 and type 2 diabetes was associated with higher prevalence of GAD antibodies and HLA-DQB1 risk genotypes than a family history of type 2 diabetes only, and was associated with earlier and more severe development of insulin deficiency, which was only partially explained by GAD antibodies and HLA.
AB - Aims: The aim was to evaluate the impact of family history of diabetes on the phenotype of patients diagnosed with Type 2 diabetes and the frequency of susceptibility genotypes. Methods: Patients with Type 2 diabetes with family history for both Type 1 and Type 2 diabetes (FHMIX, n = 196) or Type 2 diabetes only (FHT2, n = 139) matched for age, sex, BMI and age at diagnosis, underwent an oral glucose tolerance test and a combined glucagon test and insulin tolerance test. Glutamic acid decarboxylase (GAD) antibodies and major Type 1 and Type 2 diabetes susceptibility gene variants were analysed. Patients were stratified into groups according to family history or GAD antibody positivity (GADA+, GADA-) or a combination of these (GADA+/FHMIX, GADA+/FHT2, GADA-/FHMIX, GADA-/FHT2). Results: Compared with other patients, those with FHMIX more often had GAD antibodies (14.3 vs. 4.3%, P = 0.003), and those with both FHMIX and GAD antibodies had the highest frequency of insulin deficiency (stimulated serum C-peptide < 0.7 nmol/l, GADA+/FHMIX 46.4% vs. GADA-/FHMIX 9.5% (P < 0.00001), GADA-/FHT2 4.5% (P < 0.00001), GADA+/FHT2 0%). Patients with GADA+/FHMIX more often had HLA-DQB1 risk genotypes compared with patients with GADA-/FHMIX or GADA-/FHT2D (47 vs. 23 or 14%, P = 0.05 and P < 0.00001, respectively). In logistic regression analyses, FHMIX, GAD antibody positivity and HLA risk genotypes were independently associated with insulin deficiency. Conclusion: A family history for both type 1 and type 2 diabetes was associated with higher prevalence of GAD antibodies and HLA-DQB1 risk genotypes than a family history of type 2 diabetes only, and was associated with earlier and more severe development of insulin deficiency, which was only partially explained by GAD antibodies and HLA.
UR - http://www.scopus.com/inward/record.url?scp=84876349276&partnerID=8YFLogxK
U2 - 10.1111/dme.12069
DO - 10.1111/dme.12069
M3 - Journal article
C2 - 23157220
AN - SCOPUS:84876349276
SN - 0742-3071
VL - 30
JO - Diabetic Medicine
JF - Diabetic Medicine
IS - 5
ER -
